Liver Cancer
Copyright ©The Author(s) 2002. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Oct 15, 2002; 8(5): 804-807
Published online Oct 15, 2002. doi: 10.3748/wjg.v8.i5.804
Association of hTcf-4 gene expression and mutation with clinicopathological characteristics of hepatocellular carcinoma
Ying Jiang, Xin-Da Zhou, Yin-Kun Liu, Xin Wu, Xiao-Wu Huang
Ying Jiang, Xin-Da Zhou, Yin-Kun Liu, Xin Wu, Xiao-Wu Huang, Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Shanghai 200032, China
Author contributions: All authors contributed equally to the work.
Supported by National Natural Science Foundation of China, No.30070743
Correspondence to: Dr. Xin-Da Zhou, Liver Cancer Institute, Zhong Shan Hospital, Fudan University, 136 Yi Xue Yuan Road, Shanghai 200032, China. czjy@yahoo.com
Telephone: +86-21-64041990-2736 Fax: +86-21-64037181
Received: February 13, 2002
Revised: May 22, 2002
Accepted: May 26, 2002
Published online: October 15, 2002
Abstract

AIM: Hepatocellular carcinoma (HCC) is a significant health problem in China. But the molecular mechanisms of HCC remains unclear. APC/β-Catenin/Tcf signaling pathway, also known as Wnt pathway, plays a critical role in the development and oncogenesis. As little is known about the alteration of human T-cell transcription factor-4 (hTcf-4) gene in HCC, it is of interest to study the expression and mutation of hTcf-4 gene in HCC and the relationship between hTcf-4 gene and progression of HCC.

METHODS: Reverse transcription-polymerase chain reaction (RT-PCR) method was used to detect the expression of hTcf-4 mRNA in 32 HCC and para-cancerous tissues and 5 normal liver tissues. PCR-single strand conformation polymorphism (PCR-SSCP) method was used to detect the mutation of hTcf-4 exons 1, 4, 9 and 15 in HCC. The correlation of expression and mutation of the hTcf-4 gene with clinicopathological characteristics of HCC was also analyzed.

RESULTS: RT-PCR showed that the expression rate of hTcf-4 mRNA in HCC, para-cancerous tissues and normal liver tissues was 90.6%, 71.9% and 80%, respectively. The gene expression level in tumor was 0.71 ± 0.13, much higher than that in para-cancerous liver 0.29 ± 005 and normal liver 0.26 ± 0.05 (P < 0.001), although there was no significant difference in gene expression level between para-cancerous tissues and normal liver (P > 0.05). Furthermore, hTcf-4 gene expression was closely associated with tumor capsule status and intrahepatic metastasis of HCC. On SSCP, 2 of 32 cases of HCC (6.25%) displayed characteristic mutational mobility shifts in exon 15 of the hTcf-4 gene. No abnormal shifting bands were observed in para-cancerous tissues.

CONCLUSION: The high expression level of hTcf-4 in HCC, especially in tumors with metastasis, suggests that the over-expression of hTcf-4 gene may be closely associated with development and progression of HCC, but the mutation of this gene seemed to play less important role in this respect.

Keywords: $[Keywords]